Switching Biologics in Psoriasis Boosts Effectiveness but Raises Infection Risk
Interclass biologic switching can improve outcomes, but it also increases infection rates.
Previous Post
AMA calls for expert clinical oversight of the use of AI in healthcare
Next Post
Taking the Next Steps to Advance Supportive Care in Leukemia
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago